Among these therapies, oral semaglutide has emerged as a revolutionary advancement, offering patients the benefits of GLP-1 treatment without injections
For a deeper guide, you can also read about eating on GLP-1 with tiny appetite
Weekly semaglutide at 2.4 mg can achieve weight reductions of 10%12%, while tirzepatide has even demonstrated marked improvement in specific trials, reaching 5%20%+ ( More importantly, cardiovascular and renal outcome studies have demonstrated that GLP-1RAs and related multi-receptor agonists not only lower body weight and blood glucose but also significantly reduce the risk of major adverse cardiovascular events (MACE) and the worsening of renal function
"Further, while we acknowledge the corrective and preventive actions that your site has taken or plans to take, your written response is inadequate because it does not provide sufficient details about how you, as a clinical investigator, will ensure adequate oversight of the study procedures (for example, adherence to eligibility requirements)
Following semaglutide administration alone, the major fraction of semaglutide binds to albumin at the injection site, which results in protracted absorption into the circulation occurring slowly via the lymph
Weight management is typically a gradual process, and response timelines cannot be predicted
